These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35738450)
1. Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5α-tetrahydrocorticosterone versus conventional glucocorticoids. Abernethie AJ; Gastaldello A; Maltese G; Morgan RA; McInnes KJ; Small GR; Walker BR; Livingstone DE; Hadoke PW; Andrew R Eur J Pharmacol; 2022 Aug; 929():175111. PubMed ID: 35738450 [TBL] [Abstract][Full Text] [Related]
2. 5α-Tetrahydrocorticosterone: A topical anti-inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis. Livingstone DEW; Sooy K; Sykes C; Webster SP; Walker BR; Andrew R Br J Pharmacol; 2024 Apr; 181(8):1256-1267. PubMed ID: 37990638 [TBL] [Abstract][Full Text] [Related]
3. Safer topical treatment for inflammation using 5α-tetrahydrocorticosterone in mouse models. Gastaldello A; Livingstone DE; Abernethie AJ; Tsang N; Walker BR; Hadoke PW; Andrew R Biochem Pharmacol; 2017 Apr; 129():73-84. PubMed ID: 28131845 [TBL] [Abstract][Full Text] [Related]
4. 5α-reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects. Yang C; Nixon M; Kenyon CJ; Livingstone DE; Duffin R; Rossi AG; Walker BR; Andrew R Br J Pharmacol; 2011 Nov; 164(6):1661-71. PubMed ID: 21542833 [TBL] [Abstract][Full Text] [Related]
5. 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. McInnes KJ; Kenyon CJ; Chapman KE; Livingstone DE; Macdonald LJ; Walker BR; Andrew R J Biol Chem; 2004 May; 279(22):22908-12. PubMed ID: 15044432 [TBL] [Abstract][Full Text] [Related]
6. Species-specific regulation of angiogenesis by glucocorticoids reveals contrasting effects on inflammatory and angiogenic pathways. Morgan R; Keen J; Halligan D; O'Callaghan A; Andrew R; Livingstone D; Abernethie A; Maltese G; Walker B; Hadoke P PLoS One; 2018; 13(2):e0192746. PubMed ID: 29447208 [TBL] [Abstract][Full Text] [Related]
7. 5α-Reduced glucocorticoids: a story of natural selection. Nixon M; Upreti R; Andrew R J Endocrinol; 2012 Feb; 212(2):111-27. PubMed ID: 21903862 [TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Tanaka J; Fujita H; Matsuda S; Toku K; Sakanaka M; Maeda N Glia; 1997 May; 20(1):23-37. PubMed ID: 9145302 [TBL] [Abstract][Full Text] [Related]
13. Synergism of glucocorticoid hormone with growth hormone for female-specific mouse Cyp3a44 gene expression. Sakuma T; Bhadhprasit W; Hashita T; Nemoto N Drug Metab Dispos; 2008 May; 36(5):878-84. PubMed ID: 18256201 [TBL] [Abstract][Full Text] [Related]
14. Involvement of glucocorticoid receptor and pregnane X receptor in the regulation of mouse CYP3A44 female-predominant expression by glucocorticoid hormone. Bhadhprasit W; Sakuma T; Hatakeyama N; Fuwa M; Kitajima K; Nemoto N Drug Metab Dispos; 2007 Oct; 35(10):1880-5. PubMed ID: 17640954 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNA. Khan MA; Canhoto AJ; Housley PR; Creek KE; Pirisi L Exp Cell Res; 1997 Oct; 236(1):304-10. PubMed ID: 9344611 [TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro growth stimulation of murine hepatoma cells by glucocorticoid. Lui WY; Chi CW; Chang YF; Chu HW; Hsieh CC; Yin PH; Liu TY; Ou YR; P'eng FK Anticancer Res; 2002; 22(3):1413-22. PubMed ID: 12168818 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. Chen A; Vaughan J; Vale WW Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: evidence for glucocorticoid receptor-mediated regulation. Kol S; Ben-Shlomo I; Payne DW; Ando M; Rohan RM; Adashi EY Mol Cell Endocrinol; 1998 Feb; 137(2):117-25. PubMed ID: 9605513 [TBL] [Abstract][Full Text] [Related]
19. Protection against hypoxic-ischemic damage with corticosterone and dexamethasone: inhibition of effect by a glucocorticoid antagonist RU38486. Tuor UI; Del Bigio MR Brain Res; 1996 Dec; 743(1-2):258-62. PubMed ID: 9017253 [TBL] [Abstract][Full Text] [Related]